Universe Pharmaceuticals Valuation
| UPC Stock | USD 0.09 0.0009 1.01% |
Universe Pharmaceuticals seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of Universe Pharmaceuticals from inspecting the company fundamentals such as Operating Margin of (0.14) %, shares outstanding of 380.63 K, and Return On Equity of -0.5 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Universe Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Universe Pharmaceuticals is based on 3 months time horizon. Increasing Universe Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Universe Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Universe Stock. However, Universe Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0881 | Real 0.0846 | Hype 0.11 | Naive 0.0232 |
The real value of Universe Stock, also known as its intrinsic value, is the underlying worth of Universe Pharmaceuticals Company, which is reflected in its stock price. It is based on Universe Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Universe Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Universe Pharmaceuticals helps investors to forecast how Universe stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Universe Pharmaceuticals more accurately as focusing exclusively on Universe Pharmaceuticals' fundamentals will not take into account other important factors: Universe Pharmaceuticals Total Value Analysis
Universe Pharmaceuticals is at this time projected to have company total value of (3.57 M) with market capitalization of 33.53 K, debt of 5.48 M, and cash on hands of 28.58 M. The negative valuation of Universe Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Universe Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.57 M) | 33.53 K | 5.48 M | 28.58 M |
Universe Pharmaceuticals Investor Information
The company has Price to Book (P/B) ratio of 0.05. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 3054.0. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 24th of March 2025. Based on the key indicators related to Universe Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Universe Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Universe Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Universe Pharmaceuticals has an asset utilization ratio of 60.63 percent. This indicates that the Company is making $0.61 for each dollar of assets. An increasing asset utilization means that Universe Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Universe Pharmaceuticals Ownership Allocation
About 95.39 % of Universe Pharmaceuticals outstanding shares are held by general public with 0.91 (%) owned by insiders and only 3.7 % by institutional holders.Universe Pharmaceuticals Profitability Analysis
The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 7.56 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Universe Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Universe Pharmaceuticals and how it compares across the competition.
About Universe Pharmaceuticals Valuation
The stock valuation mechanism determines Universe Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Universe Pharmaceuticals. We calculate exposure to Universe Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Universe Pharmaceuticals's related companies.Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Universe Pharmaceuticals is traded on NASDAQ Exchange in the United States.
Universe Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.6 M | |
| Quarterly Earnings Growth Y O Y | -0.82 |
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |